基于FVC变化轨迹对肌萎缩侧索硬化患者进行分类:组基轨迹分析
研究基于837例ALS患者队列建立FVC轨迹组基轨迹模型,并在PRO-ACT数据库7461例患者中验证。识别出稳定低值、快速进展和缓慢进展三种轨迹,轨迹组别预测呼吸功能不全的一致性统计量为0.78(95%CI 0.76-0.79)。
要点
- ALS患者FVC轨迹可分为稳定低值、快速进展和缓慢进展三组。
- 快速进展组诊断延迟短、延髓起病多、基线ALSFRS-R总分低。
- 模型预测外部队列呼吸功能不全一致性统计量0.78(95%CI 0.76-0.79)。
核心结论
- 建立了ALS患者FVC进展的组基轨迹模型,并在外部队列中验证其预测呼吸功能不全的能力。
研究设计与样本
- 从2006至2015年单中心837例ALS患者队列推导组基轨迹模型,并应用于PRO-ACT数据库7461例ALS患者进行验证。
主要发现
- 识别出稳定低值、快速进展和缓慢进展三种FVC轨迹。
- 与缓慢进展组相比,快速进展组诊断延迟更短、延髓起病更多、基线ALSFRS-R总分更低。
- 稳定低值组诊断延迟更短、BMI更低、延髓起病更多、ALSFRS-R总分更低,且ALSFRS-R端坐呼吸评分低于4更常见。
- 预测的轨迹组别在PRO-ACT队列中预测呼吸功能不全的一致性统计量为0.78(95%CI 0.76-0.79)。
临床怎么用
- 该轨迹模型可用于识别ALS患者中呼吸功能快速进展的高风险人群,为未来研究聚焦快速进展者提供依据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Rationale: A model for stratifying progression of respiratory muscle weakness in amyotrophic lateral sclerosis (ALS) would identify disease mechanisms and phenotypes suitable for future investigations. This study sought to categorize progression of FVC after presentation to an outpatient ALS clinic.Objectives: To identify clinical phenotypes of ALS respiratory progression based on FVC trajectories over time.Methods: We derived a group-based trajectory model from a single-center cohort of 837 patients with ALS who presented between 2006 and 2015. We applied our model to the Pooled Resource Open-Access ALS Clinical Trials (PRO-ACT) database with 7,461 patients with ALS. Baseline characteristics at first visit were used as predictors of trajectory group membership. The primary outcome was trajectory of FVC over time in months.Measurements and Main Results: We found three trajectories of FVC over time, termed "stable low," "rapid progressor," and "slow progressor." Compared with the slow progressors, the rapid progressors had shorter diagnosis delay, more bulbar-onset disease, and a lower ALS Functional Rating Scale-Revised (ALSFRS-R) total score at baseline. The stable low group had a shorter diagnosis delay, lower body mass index, more bulbar-onset disease, lower ALSFRS-R total score, and were more likely to have an ALSFRS-R orthopnea score lower than 4 compared with the slow progressors. We found that projected group membership predicted respiratory insufficiency in the PRO-ACT cohort (concordance statistic = 0.78, 95% CI, 0.76-0.79).Conclusions: We derived a group-based trajectory model for FVC progression in ALS, which validated against the outcome of respiratory insufficiency in an external cohort. Future studies may focus on patients predicted to be rapid progressors.
引用
- Ackrivo J, Hansen-Flaschen J, Jones BL, et al. Classifying Patients with Amyotrophic Lateral Sclerosis by Changes in FVC. A Group-based Trajectory Analysis. Am J Respir Crit Care Med. 2019. PMID: 31322417. doi:10.1164/rccm.201902-0344OC
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。